FibroBiologics Completes Manufacturing Of Third Batch Of CYWC628 Drug Product For Ongoing Phase 1/2 Clinical Trial In Patients With Diabetic Foot Ulcers

뉴스 본문을 불러오고 있어요.

FibroBiologics Completes Manufacturing Of Third Batch Of CYWC628 Drug Product For Ongoing Phase 1/2 Clinical Trial In Patients With Diabetic Foot Ulcers | 웨이프 WAPE

FibroBiologics Completes Manufacturing Of Third Batch Of CYWC628 Drug Product For Ongoing Phase 1/2 Clinical Trial In Patients With Diabetic Foot Ulcers

기사 요약

관련 종목

댓글 —